SQUALENE COMPOUNDS AS MODULATORS OF LDL-RECEPTOR EXPRESSION
申请人:OXFORD UNIVERSITY INNOVATION LIMITED
公开号:US20170260126A1
公开(公告)日:2017-09-14
The present invention relates to compounds that modify low density lipoprotein receptor (LDLR) expression. The compounds have the structural formula I shown below:
wherein m, R
1
, n, R
2
and R
3
are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with elevated levels of low density lipoprotein cholesterol (LDL-C).
Cavallini; Massarani, Farmaco, Edizione Scientifica, 1954, vol. 9, p. 405,411